Details of the Drug Reposition

General Information of This Drug (ID: DM6N05H)

Drug Name	BIO-11006 DM6N05H

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Non-small-cell lung cancer	DIS5Y6R9	2C25.Y	Phase 2	[1]
Chronic obstructive pulmonary disease	DISQCIRF	CA22	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT00648245) Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD. U.S. National Institutes of Health.